Booster shot: Pfizer-BioNTech to seek FDA approval for 3rd dose to
Booster shot: Pfizer-BioNTech to seek FDA approval for 3rd dose to
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above
The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for
booster dose in bangalore IISC in Bengaluru is getting ready for phase 1 trials and has sought financial support from the govt to run toxicity and clinical trials
kerala guessing dear A booster dose of the vaccines helps to fight against COVID-19 This booster dose aims to provide better and enhanced immunity against the
Regular
price
111.00 ₹ INR
Regular
price
111.00 ₹ INR
Sale
price
111.00 ₹ INR
Unit price
/
per